A Network Meta-Analysis of Randomized, Controlled Trials of Ustekinumab and Adalimumab for Moderate-To-Severe Psoriasis

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.03.532
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bapineuzumab for Mild to Moderate Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Trials

BMC Neurology
MedicineNeurology
2017English

Efficacy of Progesterone for Moderate to Severe Traumatic Brain Injury: A Meta-Analysis of Randomized Clinical Trials

Scientific Reports
Multidisciplinary
2015English

Effects of Fish Oil Supplement on Psoriasis: A Meta-Analysis of Randomized Controlled Trials

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2019English

Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)

British Journal of Dermatology
DermatologyMedicine
2014English

Fluid Resuscitation in Patients With Severe Burns: A Meta-Analysis of Randomized Controlled Trials

Academic Emergency Medicine
MedicineEmergency Medicine
2017English

Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Thrombolysis Versus Anticoagulation for the Initial Treatment of Moderate Pulmonary Embolism: A Meta-Analysis of Randomized Controlled Trials

Respiratory Care
MedicinePulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2014English

Fluoxetine for Stroke Recovery: Meta-Analysis of Randomized Controlled Trials

International Journal of Stroke
Neurology
2019English

Interventions for Management of Post-Stroke Depression: A Bayesian Network Meta-Analysis of 23 Randomized Controlled Trials

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy